DSpace Repository

Enhancing risk prediction for diabetes, hypertension, and heart disease using SMOTE ENN balancing with PCA and gradient boosting in healthcare AI

Show simple item record

dc.contributor.author Paul, Rahat Tapon
dc.contributor.author Assaduzzaman, Md
dc.contributor.author Fahad, Nafiz
dc.contributor.author Hossen, Md Jakir
dc.date.accessioned 2026-11-04T11:15:00Z
dc.date.available 2026-11-04T11:15:00Z
dc.date.issued 2026-03
dc.identifier.uri http://192.168.40.123:8080/handle/123456789/18452
dc.description Articles en_US
dc.description.abstract Predicting chronic disease remains a crucial problem, particularly in low-resource environments where accurate and timely predictions are of utmost importance. Machine learning methods do not adequately generalize, encounter data imbalance and computation issues when used. In this study, an improved model that makes predictions using Synthetic minority over-sampling technique and edited nearest neighbor balancing techniques and Principal Component Analysis and Gradient Boosting to predict chronic diseases based on readily available clinical profiles is proposed. The dataset used in this study was retrieved from provide precise source: Kaggle dataset. It contains over 1500 anonymized patient records and includes 15 features such as demographic, lifestyle, and clinical measures. Standardized encoding labels, and adjusting classes using SMOTE-ENN have been completed before the PCA was conducted to improve computation speed and reduce overfitting. Decision Tree, Random Forest, LightGBM, XGBoost have been used for comparison to suggest the best performing model seen to be Gradient Boosting. PCA is performed, and the Gradient Boosting approach produces better results. Precision measures how often the classification system is correct when making a positive test result, while recall is determined using a contingency table, and the F1 score, the possibility of modeling outcomes out of 100 trials. The model proposed in the experiment provides the following outputs: Accuracy (CV: 99.33 %, CI: 98.90 %–99.50 %), Precision (CV: 99 %, CI: 98 %–99.5 %), Recall (CV: 99 %, CI: 98 %–99.5 %), F1-Score (CV: 99 %, CI: 98 %–99.5 %). The model's performance was evaluated using cross-validation, yielding an accuracy of 98.90 %. The classifying system performance is specified by the ROC-AUC ranking. It outperforms the model making indefinite projections; its ROC-AUC value is greater than 0.99. The suggested model is a robust, interpretable, and high-precision approach for the early detection of chronic conditions. Therefore, the suggested machine learning system can deliver a considerable promise with respect to creating patient-oriented outcomes. en_US
dc.language.iso en_US en_US
dc.publisher Scopus en_US
dc.subject Chronic disease en_US
dc.subject SMOTE-ENN en_US
dc.subject PCA en_US
dc.subject Gradient boosting en_US
dc.subject Machine learning en_US
dc.title Enhancing risk prediction for diabetes, hypertension, and heart disease using SMOTE ENN balancing with PCA and gradient boosting in healthcare AI en_US
dc.type Article en_US


Files in this item

This item appears in the following Collection(s)

Show simple item record

Search DSpace


Browse

My Account

Statistics